Rational Design of Benzofuran-Linked Isatin Derivatives as MTDLs Targeting MAO-B and Cholinesterases: Synthesis, in silico Insights, and Neuroprotection Studies
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-26
DOI: 10.2147/dddt.s641968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Wagdy M Eldehna und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Neurodegenerative disorders are multifactorial diseases associated with oxid active stress, mitochondrial dysfunction, and neurotransmitter imbalance, leading to progressive neuronal loss. Since monoamine oxidase-B (MAO-B) contributes to dopamine metabolism and reactive oxygen species generation, it represents an attractive therapeutic target for anti-neurodegenerative drug discovery. This study aimed to develop novel benzofuran-isatin hybrids within a multitarget-directed ligand (MTDL) strategy to achieve selective MAO-B inhibition combined with cholinesterase inhibitory and neuroprotective activities.
Methods
Twelve target compounds were synthesized and characterized using 1 H NMR, 13 C NMR, and LRMS analyses. The synthesized compounds were evaluated for MAO-A and MAO-B inhibition, while the most promising candidate was further investigated for inhibition kinetics, cholinesterase inhibitory activity, and neuroprotective effects against Aβ 1-42 -induced toxicity in SH-SY5Y cells. Molecular docking, molecular dynamics simulations, and in silico ADME prediction were also performed.
Results
The synthesized compounds displayed weak-to-moderate MAO-A inhibition (IC 50 = 2.56 to > 40 μM) and potent MAO-B inhibition (IC 50 = 0.016– 2.65 μM) with excellent isoform selectivity. The 7-methyl derivatives 7e and 7k emerged as the most potent MAO-B inhibitors, displaying IC 50 values of 0.016 and 0.073 μM with selectivity indices of 852.50 and 547.96, respectively. Kinetic studies demonstrated that compound 7e acts as a competitive MAO-B inhibitor (K I = 0.012 μM). Furthermore, 7e exhibited potent AChE inhibition (IC 50 = 0.091 μM), comparable to donepezil, together with moderate BuChE inhibition and significant neuroprotective activity against Aβ 1-42 -induced toxicity in SH-SY5Y cells. Molecular docking and molecular dynamics simulations supported favorable and stable binding of the active compounds within the MAO-B and AChE active sites. In addition, in silico ADME prediction suggested acceptable drug-likeness and CNS-related pharmacokinetic properties.
Conclusion
These findings identify benzofuran-isatin hybrids, particularly compound 7e , as promising multifunctional candidates for the treatment of neurodegenerative disorders. Future studies should focus on in vivo validation of compound 7e , including its pharmacokinetic behavior, brain exposure, safety, and therapeutic efficacy in relevant models of Alzheimer’s and Parkinson’s diseases.
Zitieren
APA
Eldehna, W. M., El-Damasy, A. K., Lim, J., Elsayed, Z. M., Al-Warhi, T., El-Hamaky, A. A., Abusabaa, A. H., Elbadawi, M. M., Paik, M., Keum, G., Elnagar, M. R., Negmeldin, A. T., Kim, H., & Tawfik, H. O. (2026). Rational Design of Benzofuran-Linked Isatin Derivatives as MTDLs Targeting MAO-B and Cholinesterases: Synthesis, in silico Insights, and Neuroprotection Studies. Drug Design, Development and Therapy, Volume 20, 1-26. https://doi.org/10.2147/dddt.s641968
Vancouver
Eldehna WM, El-Damasy AK, Lim J, Elsayed ZM, Al-Warhi T, El-Hamaky AA, et al. Rational Design of Benzofuran-Linked Isatin Derivatives as MTDLs Targeting MAO-B and Cholinesterases: Synthesis, in silico Insights, and Neuroprotection Studies. Drug Design, Development and Therapy. 2026;Volume 20:1-26. doi:10.2147/dddt.s641968
BibTeX
@article{Eldehna2026,
author = {Eldehna, Wagdy M and El-Damasy, Ashraf K and Lim, Jaeyeop and Elsayed, Zainab M and Al-Warhi, Tarfah and El-Hamaky, Anwar A and Abusabaa, Ahmed HA and Elbadawi, Mostafa M and Paik, Man-Jeong and Keum, Gyochang and Elnagar, Mohamed R and Negmeldin, Ahmed T and Kim, Hoon and Tawfik, Haytham O},
title = {Rational Design of Benzofuran-Linked Isatin Derivatives as MTDLs Targeting MAO-B and Cholinesterases: Synthesis, in silico Insights, and Neuroprotection Studies},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--26},
doi = {10.2147/dddt.s641968}
}
EUVIMED